Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
24.29
+0.09 (0.37%)
At close: Mar 28, 2025, 4:00 PM
25.16
+0.87 (3.58%)
After-hours: Mar 28, 2025, 6:25 PM EDT
Simulations Plus Employees
As of August 31, 2024, Simulations Plus had 247 total employees, including 243 full-time and 4 part-time employees. The number of employees increased by 50 or 25.38% compared to the previous year.
Employees
247
Change (1Y)
50
Growth (1Y)
25.38%
Revenue / Employee
$301,364
Profits / Employee
$33,259
Market Cap
488.05M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SLP News
- 4 days ago - Top 3 Health Care Stocks That Are Set To Fly This Month - Benzinga
- 10 days ago - Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date - Business Wire
- 20 days ago - Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum - Business Wire
- 7 weeks ago - Simulations Plus to Participate in Upcoming Healthcare Investor Conferences - Business Wire
- 2 months ago - Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements - Business Wire
- 2 months ago - Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024 - Business Wire
- 2 months ago - Simulations Plus Supported Development of Every FDA-Approved Drug in 2024 - Business Wire
- 2 months ago - Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript - Seeking Alpha